CFIHX
Price
$82.37
Change
+$0.43 (+0.52%)
Updated
Jun 12 closing price
Net Assets
127.98B
EDIRX
Price
$12.41
Change
+$0.01 (+0.08%)
Updated
Jun 12 closing price
Net Assets
315.55M
Interact to see
Advertisement

CFIHX vs EDIRX

Header iconCFIHX vs EDIRX Comparison
Open Charts CFIHX vs EDIRXBanner chart's image
CFIHX vs EDIRX Comparison Chart in %
View a ticker or compare two or three
VS
CFIHX vs. EDIRX commentary
Jun 15, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CFIHX is a Buy and EDIRX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
CFIHX has more cash in the bank: 128B vs. EDIRX (316M). EDIRX pays higher dividends than CFIHX: EDIRX (4.68) vs CFIHX (3.01). CFIHX was incepted earlier than EDIRX: CFIHX (9 years) vs EDIRX (20 years). EDIRX (1.42) is less costly to investors than CFIHX (0.26). EDIRX is a more actively managed with annual turnover of: 102.00 vs. CFIHX (50.00). EDIRX has a lower initial minimum investment than CFIHX: EDIRX (1000) vs CFIHX (1000000). EDIRX annual gain was more profitable for investors over the last year : 16.70 vs. CFIHX (11.74). CFIHX return over 5 years is better than : 37.59 vs. EDIRX (31.86).
CFIHXEDIRXCFIHX / EDIRX
Total Expense Ratio0.261.4218%
Annual Report Gross Expense Ratio0.261.4218%
Fund Existence9 years20 years-
Gain YTD7.9186.663119%
Front LoadN/AN/A-
Min. Initial Investment10000001000100,000%
Min. Initial Investment IRAN/AN/A-
Net Assets128B316M40,506%
Annual Yield % from dividends3.014.6864%
Returns for 1 year11.7416.7070%
Returns for 3 years42.4844.4296%
Returns for 5 years37.5931.86118%
Returns for 10 yearsN/A96.51-
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
AMFEX21.260.17
+0.81%
AAMA Equity
FPURX28.530.22
+0.78%
Fidelity Puritan
FSGAX47.480.12
+0.25%
Franklin Small-Mid Cap Growth Adv
GTCEX24.860.06
+0.24%
Glenmede Strategic Equity
MSCMX16.450.04
+0.24%
Morgan Stanley Insight C